Immupharma (IMM)

 

Latest News

Grant of Options

RNS Number: 8456K Immupharma PLC 12 July 2017 12 July 2017 Grant of Options ImmuPharma PLC (LSE:IMM), ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, announces the approval of the grant of options over 1,40 0,000 ordinary shares of 10p each ("Ordinary Shares") to certain of its non-executive Directors repr...

Result of AGM

RNS Number: 7583J Immupharma PLC 30 June 2017 FOR IMMEDIATE RELEASE 30 JUNE 2017 2017 ANNUAL GENERAL MEETING - ALL RESOLUTIONS PASSED ImmuPharma PLC (LSE:IMM) , ("ImmuPharma" or the "Company"), the specialist drug discovery and development company, held its AGM earlier today and is pleased to announce that all res...

Broker Forecast - Northland Capital issues a broker note on ImmuPharma PLC

Northland Capital today reaffirms its buy investment rating on ImmuPharma PLC (LON:IMM) and raised its price targe...

Update on LupuzorT Pivotal Phase III Study

RNS Number: 5921J Immupharma PLC 30 June 2017 30 JUNE 2017 ImmuPharma PLC ("ImmuPharma" or the "Company") Update on Lupuzor Pivotal Phase III Study Annual General Meeting and Investor Presentation: Today starting at 10.30am ImmuPharma PLC (LSE:IMM) , the specialist drug discovery and development company, is pleased to provide an update...

All News

DateHeadlineSource
12-07-17Grant of OptionsRNS
30-06-17Result of AGMRNS
30-06-17Broker Forecast - Northland Capital issues a broker note on ImmuPharma PLCStockMarketWire
30-06-17Update on LupuzorT Pivotal Phase III StudyRNS
07-06-17Annual Report & Notice of AGMRNS
01-06-17ImmuPharma losses widenStockMarketWire
01-06-17Final ResultsRNS
22-05-17Notification of Full Year ResultsRNS
17-05-17Lupuzor study on track, says ImmuPharma StockMarketWire
17-05-17Update on Lupuzor Phase III StudyRNS
31-03-17New Employee Share Option Plan & Grant of OptionsRNS
31-03-17New Employee Share Option Plan & Grant of OptionsRNS
24-03-17ImmuPharma to present at Master Investor ShowRNS
22-03-17Holding(s) in CompanyRNS
20-03-17Holding(s) in CompanyRNS
20-03-17Holding(s) in CompanyRNS
10-03-17?4.1 Million Fund Raise via Accelerated BookbuildRNS
10-03-17Accelerated Bookbuild for the Issue of EquityRNS
06-03-17Holding(s) in CompanyRNS
17-02-17Holding(s) in CompanyRNS
25-01-17Update on Lupuzor Phase III StudyRNS
24-01-17Change of AdviserRNS
29-12-16Holding(s) in CompanyRNS
22-12-16ImmuPharma completes Lupuzor patient recruitment StockMarketWire
22-12-16Update on Lupuzor Pivotal Phase III StudyRNS
16-11-16ImmuPharma update on cancer compound StockMarketWire
16-11-16Update on Cancer Compound IPP-204106 'Nucant'RNS
09-11-16Holding(s) in CompanyRNS
26-10-16Holding(s) in CompanyRNS
24-10-16ImmuPharma fundraising StockMarketWire
21-10-16Close of Accelerated BookbuildRNS
21-10-16ImmuPharma placing StockMarketWire
21-10-16Proposed Accelerated Bookbuild for Vendor PlacingRNS
30-09-16ImmuPharma losses increase StockMarketWire
30-09-16Half-year ReportRNS
14-09-16ImmuPharma update on Lupuzor study StockMarketWire
14-09-16UPDATE ON LUPUZOR'S PIVOTAL PHASE III STUDYRNS
07-09-16ImmuPharma to open new site in Lupuzor study StockMarketWire
07-09-16UPDATE ON LUPUZOR'S PIVOTAL PHASE III STUDYRNS
21-07-16Holding(s) in CompanyRNS

RSS feeds

  • Editorial news feed for LSE:IMM Editorial
  • Regulatory news feed for LSE:IMM Regulatory